(secondQuint)The Safety and Effectiveness of Megace in HIV-Infected Women.

 Patients are randomized to receive 1 of 2 doses of Megace oral suspension daily for 24 weeks; at 12 weeks, those receiving the lower dose who have not gained 5 pounds over baseline or had appetite improvement to good or excellent are escalated to the higher dose.

 Patients are evaluated at 4-week intervals.

 Dose may be adjusted to maintain a desired weight.

.

 The Safety and Effectiveness of Megace in HIV-Infected Women@highlight

To further evaluate the safety of megestrol acetate (Megace) oral suspension in the treatment of anorexia and cachexia in HIV-positive women.

 To compare the effectiveness of 2 doses of Megace by measurement of weight gain, appetite grade, and other parameters at 12 and 24 weeks.

